A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy.
Freitas R, Miranda A, Ferreira D, Relvas-Santos M, Castro F, Ferreira E, Gaiteiro C, Soares J, Cotton S, Gonçalves M, Eiras M, Santos B, Palmeira C, Correia MP, Oliveira MJ, Sarmento B, Peixoto A, Santos LL, Silva AMN, Ferreira JA.
Freitas R, et al. Among authors: ferreira e, ferreira d, ferreira ja.
J Control Release. 2024 Mar;367:540-556. doi: 10.1016/j.jconrel.2024.01.065. Epub 2024 Feb 3.
J Control Release. 2024.
PMID: 38301927